Open access
Open access
Powered by Google Translator Translator

General Interest

RCT | Donanemab slows early symptomatic Alzheimer’s progression, but raises serious safety concerns

18 Jul, 2023 | 13:51h | UTC

Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial – JAMA (free for a limited period)

Editorials:

Donanemab for Alzheimer Disease—Who Benefits and Who Is Harmed? – JAMA (free for a limited period)

Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease – JAMA (free for a limited period)

Ushering in a New Era of Alzheimer Disease Therapy – JAMA (free for a limited period)

See also: Visual Abstract

Commentary: Expert reaction to results from Eli Lilly on its anti-amyloid drug donanemab – Science Media Centre

Related: RCT | Lecanemab slows cognitive decline in early Alzheimer’s disease but raises safety concerns.

 


Health advisory on social media use in adolescence

11 Jul, 2023 | 14:03h | UTC

Health advisory on social media use in adolescence – American Psychological Association

News Release: APA panel issues recommendations for adolescent social media use – American Psychological Association

 


Cohort Study | Fewer than half of new drugs add substantial therapeutic value over existing treatments

11 Jul, 2023 | 14:01h | UTC

News Release: Fewer than half of new drugs add substantial therapeutic value over existing treatments – BMJ Newsroom

Article: Therapeutic value of first versus supplemental indications of drugs in US and Europe (2011-20): retrospective cohort study – The BMJ

Editorial: Patients need better treatments, not just more of the same – The BMJ

 


Cohort Study | A diet high in fruits, vegetables, nuts, legumes, fish, and dairy linked with decreased mortality and CVD globally

10 Jul, 2023 | 13:39h | UTC

Diet, cardiovascular disease, and mortality in 80 countries – European Heart Journal

Editorial: Identifying nutritional priorities for global health: time for a more PURE focus on protective foods – European Heart Journal

News Release: Global diet study challenges advice to limit high-fat dairy foods – European Society of Cardiology

 

Commentary on Twitter

 


Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050

26 Jun, 2023 | 01:00h | UTC

Summary: This systematic review analyzed the global burden of diabetes, including trends, projections, and attributions to risk factors. It considered data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), covering 204 countries and territories.

In 2021, an estimated 529 million people worldwide were living with diabetes. Regionally, the highest rates were observed in North Africa, the Middle East, and Oceania. Type 2 diabetes accounted for 96% of diabetes cases and 95.4% of diabetes DALYs (disability-adjusted life-years). More than half of global type 2 diabetes DALYs were attributable to high body mass index (BMI).

Predictions suggest that more than 1.31 billion people will have diabetes by 2050, with high prevalence rates in North Africa, the Middle East, and Latin America. The study notes the ongoing challenge of preventing and controlling type 2 diabetes, largely driven by increasing obesity. An understanding of disparities in risk profiles and disease burdens can inform strategies to control diabetes risk factors.

Article: Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 – The Lancet

Editorial: Diabetes: a defining disease of the 21st century – The Lancet

News Release: Global diabetes cases to soar from 529 million to 1.3 billion by 2050 – Institute for Health Metrics and Evaluation

 

Commentary on Twitter (thread – click for more)

 


Editorial | How to become a good surgeon

22 Jun, 2023 | 15:12h | UTC

How to become a good surgeon – Advances in Ophthalmology Practice and Research

 


Perspective | Benefits and pitfalls of social media in cardiology

16 Jun, 2023 | 14:13h | UTC

Impact of Social Media and Multimedia Platforms: View From the JACC: Case Reports SoMe Editors – JACC: Case Reports

 

Commentary on Twitter

 


RCT | Cannabis-based medicines show no significant relief for moderate-to-severe cancer pain

15 Jun, 2023 | 15:10h | UTC

Cannabis‐based medicines and medical cannabis for adults with cancer pain – Cochrane Library

Summary: Cannabis-based medicines for cancer pain – Cochrane Library

 


Perspective | Inside the nascent industry of AI-designed drugs

14 Jun, 2023 | 14:50h | UTC

Inside the nascent industry of AI-designed drugs – Nature (if the link is paywalled, try this one)

 


Opinion | Threats by artificial intelligence to human health and human existence

14 Jun, 2023 | 14:47h | UTC

Threats by artificial intelligence to human health and human existence – BMJ Global Health

News Release: Doctors and public health experts join calls for halt to AI R&D until it’s regulated – BMJ Newsroom

 


Pre-clinical Study | Taurine deficiency and aging, a correlation found in mice, monkeys, and worms

12 Jun, 2023 | 13:53h | UTC

Taurine deficiency as a driver of aging – Science

Invited Commentary: Taurine linked with healthy aging – Science

News Release: Taurine May Be a Key to Longer and Healthier Life – Columbia University

 

Commentary on Twitter

 


SR | Limited evidence for vitamin and mineral supplements in delaying dementia in people with mild cognitive impairment

7 Jun, 2023 | 14:09h | UTC

Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment – Cochrane Library

 

Commentary on Twitter

 


Review | How to understand the 95% confidence interval around the relative risk, odds ratio, and hazard ratio

6 Jun, 2023 | 14:37h | UTC

How to Understand the 95% Confidence Interval Around the Relative Risk, Odds Ratio, and Hazard Ratio: As Simple as It Gets – The Journal of Clinical Psychiatry

 


Perspective | How to use social media for scientific advocacy and personal branding

2 Jun, 2023 | 12:22h | UTC

How to use social media for scientific advocacy and personal branding – UEG Journal

 


SR | Individual‐level interventions for reducing occupational stress in healthcare workers

1 Jun, 2023 | 12:18h | UTC

Individual‐level interventions for reducing occupational stress in healthcare workers – Cochrane Library

News Release: Stress-management interventions may help individual healthcare workers for at least a year – Cochrane Library

 


AHA Scientific Statement | Basic life support education for schoolchildren

25 May, 2023 | 11:37h | UTC

KIDS SAVE LIVES: Basic Life Support Education for Schoolchildren: A Narrative Review and Scientific Statement From the International Liaison Committee on Resuscitation – Circulation

News Release: Learning to save lives can start as early as age 4, according to new scientific statement – American Heart Association

Top Things to Know: KIDS SAVE LIVES: Basic Life Support Education for Schoolchildren – American Heart Association

 


Perspective | Fake scientific papers are alarmingly common

24 May, 2023 | 13:18h | UTC

Fake scientific papers are alarmingly common – Science

 


Opinion Video | Questioning the reliability of nutrition science

23 May, 2023 | 13:02h | UTC

Nutrition science is entirely unreliable | Don’t trust the New York Times Well section – By Dr Vinay Prasad

 


ChatGPT’s performance on radiology board exam: strengths and shortcomings

22 May, 2023 | 13:48h | UTC

Performance of ChatGPT on a Radiology Board-style Examination: Insights into Current Strengths and Limitations – Radiology

News Release: ChatGPT passes radiology board exam – Radiological Society of North America

 


FDA warns of use of selective androgen receptor modulators (SARMs) among teens, young adults

10 May, 2023 | 16:00h | UTC

FDA Warns of Use of Selective Androgen Receptor Modulators (SARMs) Among Teens, Young Adults – U.S. Food & Drug Administration

Commentaries:

FDA issues warning for bodybuilding products marketed to teens, young adults – AAP News

Young Men Are Using Banned ‘SARM’ Supplements to Bulk Up, With Harmful Results – HealthDay


Video | Keeping up with the literature: special discussion of masking evidence

9 May, 2023 | 14:56h | UTC

Keeping up with the literature | Special discussion of Masking Evidence

 


‘Too greedy’: mass walkout at global science journal over ‘unethical’ fees

8 May, 2023 | 13:19h | UTC

‘Too greedy’: mass walkout at global science journal over ‘unethical’ fees – The Guardian

 


ChatGPT’s responses to patient questions rated higher for quality and empathy than physicians

2 May, 2023 | 14:00h | UTC

ChatGPT’s responses to patient questions rated higher for quality and empathy than physicians

Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum – JAMA Internal Medicine (free for a limited period)

Commentaries:

How Chatbots and Large Language Model Artificial Intelligence Systems Will Reshape Modern Medicine: Fountain of Creativity or Pandora’s Box? – JAMA Internal Medicine (free for a limited period)

Expert reaction to study comparing physician and AI chatbot responses to patient questions – Science Media Centre

 

Commentary on Twitter (thread – click for more)

 


ADHD Medication Misuse | 25% of students in some US schools report nonmedical use for stimulant effect

26 Apr, 2023 | 14:21h | UTC

Prescription Stimulant Medical and Nonmedical Use Among US Secondary School Students, 2005 to 2020 – JAMA Network Open

News Release: In some US schools, 1 in 4 students report misusing prescription stimulants – University of Michigan

 

Commentary on Twitter

 


Cohort Study | Beverage consumption and mortality among adults with type 2 diabetes

26 Apr, 2023 | 14:09h | UTC

Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study – The BMJ

Editorial: Beverages and health outcomes in adults with type 2 diabetes – The BMJ

Commentary: Healthy Beverage Choices May Lower Mortality Risk in Adults with Diabetes – HCP Live

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.